Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-25-033675

Options or other derivatives

  • Chief Medical Officer acquired 165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Puhlmann Markus · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-03 Grant or award : show line 1 in the form Stock option (right to buy) +165,000 165,000 D
Loading xslF345X05/ownership.xml…